Medical progress: Acromegaly.
Melmed
Shlomo
S
Department of Medicine, Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles 90048, USA. melmed@cshs.org
D000172:Acromegaly / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D000236:Adenoma / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery; D013007:Growth Hormone-Releasing Hormone / Q000097:blood; D049912:Growth Hormone-Secreting Pituitary Adenoma / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery; D019382:Human Growth Hormone / Q000031:analogs & derivatives / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D010911:Pituitary Neoplasms / Q000150:complications* / Q000532:radiotherapy / Q000601:surgery; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors; D013004:Somatostatin / Q000031:analogs & derivatives
D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I; D013007:Growth Hormone-Releasing Hormone; C406545:pegvisomant